While the growing evidence supports the critical role of beta tubulin isotypes in the way that microtubules interact with other MAPs or chemotherapeutic drugs, identifying the factors that can be responsible for the underlying mechanisms is imperative for our knowledge of Cancer Biology, with the hope of developing more effective treatments. This evidence concerns the gene TUBB and cancer.